Clinical Trial Update: Vorinostat in Treating Patients With Metastatic or Unresectable Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 trial of vorinostat in patients with metastatic or unresectable melanoma has completed, with results posted in 2014. The study encompassed ocular mela…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intraocular Melanoma
• Melanoma
• Uveal Melanoma

Drugs mentioned

• Zolinza (vorinostat)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Ciliary Body and Choroid Melanoma, Medium/Large Size, Extraocular Extension Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2014-10-03